284047-98-9 Usage
Uses
Used in Pharmaceutical Industry:
3-NITRO-5-(TRIFLUOROMETHYL)BENZALDEHYDE is used as a key intermediate in the synthesis of pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
3-NITRO-5-(TRIFLUOROMETHYL)BENZALDEHYDE is also utilized in the agrochemical industry, where it serves as an intermediate for the production of various agrochemicals, contributing to the development of effective pest control solutions.
Used in Organic Synthesis:
3-NITRO-5-(TRIFLUOROMETHYL)BENZALDEHYDE is used as a building block in organic synthesis, enabling the creation of a wide range of chemical compounds with diverse applications.
Used in Material Science:
With its potential use as a building block for the development of new materials, 3-NITRO-5-(TRIFLUOROMETHYL)BENZALDEHYDE contributes to advancements in material science, potentially leading to the discovery of innovative materials with unique properties.
It is crucial to handle 3-NITRO-5-(TRIFLUOROMETHYL)BENZALDEHYDE with care due to its hazardous properties, and to adhere to proper safety protocols during its use in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 284047-98-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,4,0,4 and 7 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 284047-98:
(8*2)+(7*8)+(6*4)+(5*0)+(4*4)+(3*7)+(2*9)+(1*8)=159
159 % 10 = 9
So 284047-98-9 is a valid CAS Registry Number.
284047-98-9Relevant academic research and scientific papers
6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS
-
Paragraph 0221-0222, (2021/11/13)
The present disclosure provides 6-heteroaryloxy benzimidazole and azabenzimidazole compounds and compositions thereof useful for inhibiting JAK2.
HETEROCYCLIC COMPOUND
-
, (2016/04/08)
The present invention relates to a compound represented by the formula (I), which is useful as an agent for the prophylaxis or treatment of epilepsy, neurodegenerative disease and the like. In the formula (I), each symbol is as defined in the specification.
PYRROLE DERIVATIVES WITH CRTH2 RECEPTOR MODULATOR ACTIVITY
-
Page/Page column 31-32, (2008/06/13)
There are provided according to the invention compounds of formula (I) in free or salt form, wherein R3, R 4, R5, R6a, R6b, Q and W are as described in the specification, process for preparing them, a
CETP INHIBITORS
-
Page/Page column 63, (2010/02/14)
Compounds of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formu
Enzymatic resolution of substituted mandelic acids
Campbell, Robert F.,Fitzpatrick, Kevin,Inghardt, Tord,Karlsson, Olle,Nilsson, Kristina,Reilly, John E.,Yet, Larry
, p. 5477 - 5481 (2007/10/03)
A series of substituted mandelic acids were prepared and subjected to enzymatic resolution utilizing Lipase PS 'Amano'.
